Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure

Blood

Volumn 104, Issue 6, 2004, Pages 1671-1678

  Chen, Jichun ^a   Lipovsky, Karen ^a   Ellison, Felicia M ^a   Calado, Rodrigo T ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; BONE MARROW HYPOPLASIA; BYSTANDER EFFECT; CELL CULTURE; CELL GROWTH; CELL INFILTRATION; COLONY FORMING UNIT S; CONTROLLED STUDY; EFFECTOR CELL; HAPLOTYPE; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; INFUSION; IRRADIATION; LYMPH NODE CELL; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; STEM CELL; STROMA CELL; T LYMPHOCYTE;

EID: 4444327634     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1115     Document Type: Article

References (34)

1. Young NS, Barrett AJ. Immune mediation of pancytopenia in myelodysplastic syndromes: pathophysiology and treatment. In: Bennett JM, ed. The Myelodysplastic Syndromes: Pathobiology and Clinical Management. New York, NY: Marcel Dekker; 2002:373-398.
2. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534-546.
3. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med. 1990;323:315-321.
4. Barnes DWH, Mole RH. Aplastic anaemia in sublethally irradiated mice given allogeneic lymph node cells. Br J Haematol. 1967;13:482-491.
5. + T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med. 1998;187:1903-1920.
6. Morley A, Blake J. An animal model of chronic aplastic marrow failure, I: late marrow failure after busulfan. Blood. 1974;44:49-56.
7. Chiu KM, Knospe WH. Immunologically mediated aplastic anemia in mice: effects of varying the source and composition of donor cells. Exp Hematol. 1987;15:269-275.
8. Chin KM, Knospe WH. Inhibitor of granulocyte-macrophage colony formation in plasma of mice rendered aplastic by allogeneic lymph node cells. Exp Hematol. 1989;17:335-339.
9. Hayashi NM, Abe F, Takita T, Nakamura T, Takeuchi T, Umezawa H. Therapy of experimental immunologically mediated aplastic anemia in mice by various immunosuppressive and antitumor agents. Transplant Proc. 1988;20:545-548.
10. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China: Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89:1065-1071.
11. Ideriha NM, Vugman I, Falcao RP. Ectopic bone marrow development in experimental busulfan-induced hypoplastic anemia in mice. Blut. 1984;48:277-284.
12. Knospe WH, Steinberg D, Speck B. Experimental immunologically mediated aplastic anemia (AA) in H-2k identical, mLs (M) locus different mice. Exp Hematol. 1983;11:542-552.
13. Knospe WH, Steinberg D, Gratwohl A, Speck B. Experimental immunologically mediated aplastic anemia (AA) in mice: cyclosporin A fails to protect against AA. Int J Cell Cloning. 1984;2:263-271.
14. Knospe WH, Husseini SG, Chiu KM, Fried W. Immunologically mediated aplastic anemia in mice: evidence of hematopoietic stromal injury and injury to hematopoietic stem cells. Exp Hematol. 1994;22:573-581.
15. Kubota K, Mizoguchi H, Miura Y, Kano S, Takaku F. Experimental hypoplastic marrow failure in the mouse. Exp Hematol. 1978;6:791-800.
16. The Jackson Laboratory. Handbook on Genetically Standardized JAX Mice. Bar Harbor, ME: The Jackson Laboratory; 1997.
17. Chen J, Harrison DE. Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood. Blood. 2002;99:561-566.
18. SAS Institute. JMP Statistics and Graphics Guide. Version 3. Cary, NC: SAS Institute; 1998.
19. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 1996;273:242-245.
20. Zhao Y, Zhan Y, Lin Y, Yang J, Harrison DE, Anderson WF. Regulation of murine hematopoietic stem cell proliferation in vivo. Blood. 2000;96:3016-3022.
21. Ellison CA, Natuik SA, McIntosh AR, Scully SA, Danilenko DM, Gartner JG. The role of interferon-r, nitric oxide and lipopolysaccharide in intestinal graft-versus-host disease developing in F1-hybrid mice. Immunology. 2003;109:440-449.
22. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood. 1995;85:1006-1016.
23. Chen J, Astle CM, Harrison DE. Hematopoietic stem cell functional failure in interleukin-2-deficient mice. J Hematother Stem Cell Res. 2002;11:905-912.
24. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997;336:1365-1372.
25. Carpenter N, Fontannaz J, Jeannet M, Nissen C, Speck B. Characteristics and clinical relevance of autolymphocytotoxins in patients with aplastic anemia. Transplantation. 1986;42:159-161.
26. Warren RP, Storb R, Thomas ED, Su PJ, Mickelson EM, Weiden PL. Autoimmune and alloimmune phenomena in patients with aplastic anemia: cytotoxicity against autologous lymphocytes and lymphocytes from HLA identical siblings. Blood. 1980;56:683-689.
27. Kaminski ER, Hows JM, Goldman JM, Batchelor JR. Pretransfused patients with severe aplastic anaemia exhibit high numbers of cytotoxic T lymphocyte precursors probably directed at non-HLA antigens. Br J Haematol. 1990;76:401-405.
28. Kaminski ER, Hows JM, Goldman JM, Batchelor JR. Lymphocytes from multi-transfused patients exhibit cytotoxicity against autologous cells. Br J Haematol. 1992;81:23-26.
29. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med. 1999;5:601-604.
30. Lam-Tse WK, Lernmark A, Drexhage HA. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity. Springer Semin Immunopathol. 2002;24:297-321.
31. Kaufman DL. Murder mysteries in type 1 diabetes. Nat Med. 2003;9:161-162.
32. Yu M, Johnson JJ, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease [abstract]. J Exp Med. 1996;183:1788.
33. Jones RE, Bourdette D, Moes N, Vandenbark A, Zamora A, Offner H. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J Immunol. 2003;170:1690-1698.
34. + TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med. 2003;197:111-119.